Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
23-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #61212
advertisement
Sabanayagam C
17
Showing records 1 to 17 |
Display all abstracts from
Sabanayagam C
100700
Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations
Qian C
British Journal of Ophthalmology
2023; 107: 1275-1280
100641
Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains
Gupta P; Fenwick EK
Scientific reports
2022; 12: 8465
100700
Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations
Nusinovici S
British Journal of Ophthalmology
2023; 107: 1275-1280
100641
Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains
Man REK
Scientific reports
2022; 12: 8465
100700
Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations
Thakur S
British Journal of Ophthalmology
2023; 107: 1275-1280
100641
Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains
Gan ATL
Scientific reports
2022; 12: 8465
100700
Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations
Soh ZD; Majithia S
British Journal of Ophthalmology
2023; 107: 1275-1280
100641
Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains
Sabanayagam C
Scientific reports
2022; 12: 8465
100700
Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations
Chee ML
British Journal of Ophthalmology
2023; 107: 1275-1280
100641
Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains
Quek D
Scientific reports
2022; 12: 8465
100700
Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations
Zhong H
British Journal of Ophthalmology
2023; 107: 1275-1280
100641
Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains
Qian C; Cheung CMG
Scientific reports
2022; 12: 8465
100700
Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations
Tham YC; Sabanayagam C
British Journal of Ophthalmology
2023; 107: 1275-1280
100641
Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains
Cheng CY
Scientific reports
2022; 12: 8465
100700
Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations
Hysi PG
British Journal of Ophthalmology
2023; 107: 1275-1280
100641
Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains
Lamoureux EL
Scientific reports
2022; 12: 8465
100700
Machine learning identifying peripheral circulating metabolites associated with intraocular pressure alterations
Cheng CY
British Journal of Ophthalmology
2023; 107: 1275-1280
Issue
23-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept